Skip to main content
Fig. 3 | Diagnostic Pathology

Fig. 3

From: Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy

Fig. 3

Relationship of different HR combination subgroups and OS in the whole series (Kaplan–Meier method and log-rank test) Legend: The four different HR combinations were associated with significant differences in patient OS (log-rank, P < 0.001). The prognosis of patients with the ER-/PR + phenotype was similar to that of patients with the ER-/PR- phenotype (P = 0.978), and patients with the ER + /PR + and ER + /PR- phenotypes had a significantly better survival outcome than the other patients (P < 0.001), patients with ER-/PR + phenotype had a higher risk of death than other patients, and the mean survival time was 100.45 months. Abbreviation: ER, estrogen receptor; PR, progesterone receptor

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us